Financial-disclosure law going into effect for drug-, device-makers

07/28/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

U.S. drug and device companies on Thursday must begin keeping records of payments made to hospitals and doctors as part of new financial disclosure rules included in the Affordable Care Act. Industry stakeholders hope the information will allay fears that these relationships adversely affect patient outcomes or result in unethical behavior.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ